InVivoMAb anti-mouse Ly6G/Ly6C BE0320-R025mg from Bio X Cell

Product Specs
ItemInVivoMAb anti-mouse Ly6G/Ly6C
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0320-R025mg
Quantity25 mg
Applicationsin vivo neutrophil depletion, Immunohistochemistry (paraffin), Immunohistochemistry (frozen), Immunofluorescence, Flow cytometry
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityMouse
TargetLy6G/Ly6C
IsotypeIgG2b, κ
CloneNIMP-R14
HostRat
Antibody TypePrimary Antibody
ImmunogenPurified BALB/c mouse neutrophils
NCBI Full Gene Namelymphocyte antigen 6 family member G
NCBI Gene AliasesGr-1, Gr1, Ly-6G
ClonalityMonoclonal
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaCancer Biology, Immunology, Innate Immunity

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

(1) Neutrophils Which Migrate to Lymph Nodes Modulate CD4⁺ T Cell Response by a PD-L1 Dependent MechanismFrontiers in immunologyJanuary 1, 2019Castell SD, Harman MF, Morón G, Maletto BA, Pistoresi-Palencia MC.

(2) Evidence that neutrophils do not promote Echis carinatus venom-induced tissue destructionNature communicationsJune 13, 2018Stackowicz J, Balbino B, Todorova B, Godon O, Iannascoli B, Jönsson F, Bruhns P, Reber LL.

(5) Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligandsThe American journal of pathologyNovember 1, 2009Chung ES, Chauhan SK, Jin Y, Nakao S, Hafezi-Moghadam A, van Rooijen N, Zhang Q, Chen L, Dana R.

(6) Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activationThe American journal of pathologyNovember 1, 2009Abdollahi-Roodsaz S, Joosten LA, Koenders MI, van den Brand BT, van de Loo FA, van den Berg WB.

InVivoMAb anti-mouse Ly6G/Ly6C